Literature DB >> 6786606

Preliminary evaluation of a single-day tubeless test of pancreatic function.

C J Mitchell, H P Field, F G Simpson, A Parkin, J Kelleher, M S Losowsky.   

Abstract

The test for pancreatic exocrine function using N-benzoyl-L-tyrosyl-p-aminobenzoic acid (BTP test) does not require duodenal intubation, but misleadingly abnormal results often occur in patients with liver or bowel disease because the p-aminobenzoic acid (PABA) released by chymotrypsin hydrolysis of the peptide either is not conjugated or is malabsorbed. This study evaluated a modified BTP test, using a tracer dose of 14C-PABA to eliminate misleading results, to assess exocrine function from a single six-hour collection of urine. The test clearly distinguished all patients with pancreatic steatorrhoea from normal subjects and identified patients with less severe pancreatitis as often as did the Lundh test. Furthermore, in patients with bowel or liver disease the misleadingly abnormal results of the unmodified BTP test were eliminated by the modified test in all but one case. These findings suggest that the modified BTP test provides a practical alternative to conventional tests of pancreatic function that entail duodenal intubation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786606      PMCID: PMC1505724          DOI: 10.1136/bmj.282.6278.1751

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  [Diagnosis of exocrine pancreatic malfunction with a synthetic peptide specific for chymotrypsine (author's transl)].

Authors:  W Bornschein; F L Goldmann; J Dressler
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

3.  [The oral administration of N-benzoyl-L-tyrosyl-paraaminobenzoic acid (PFT) in the assessment of exocrine pancreatic function and its value within the diagnostic approach to pancreatic disease (author's transl)].

Authors:  F Fettes; K Gyr; M Singeisen; L Kayasseh; G A Stalder
Journal:  Z Gastroenterol       Date:  1978-03       Impact factor: 2.000

4.  Study on the exocrine pancreatic function by the oral administration of N-benzoyl-L-tyrosyl-para-aminobenzoic acid.

Authors:  K Kato; S Izumiyama; M Sakakura; A Hirayama; K Ishii
Journal:  Gastroenterol Jpn       Date:  1977

5.  [Indirect assessment of exocrine pancreatic function by oral administration of a synthetic peptide, N-benzoyl-L-tyrosyl-para-amino-benzoic-acid (PABA test) (author's transl)].

Authors:  A Ribet; J Frexinos; J Escourrou; N Vaysse; Y Arany; M Varignon
Journal:  Gastroenterol Clin Biol       Date:  1979-03

6.  Development of a dual label Schilling test for pancreatic exocrine function based on the differential absorption of cobalamin bound to intrinsic factor and R protein.

Authors:  W R Brugge; J S Goff; N C Allen; E R Podell; R H Allen
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

7.  [Methodological and first clinical investigations using a new pancreatic function test].

Authors:  W Bornschein; F L Goldmann; M Otte
Journal:  Clin Chim Acta       Date:  1976-02-16       Impact factor: 3.786

8.  Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT).

Authors:  K Gyr; G A Stalder; I Schiffmann; C Fehr; D Vonderschmitt; H Fahrlaender
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

9.  The diagnostic value of the oral pancreatic function test.

Authors:  C J Mitchell; C S Humphrey; A W Bullen; J Kelleher
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

10.  Improved diagnostic accuracy of a modified oral pancreatic function test.

Authors:  C J Mitchell; C S Humphrey; A W Bullen; J Kelleher; M S Losowsky
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

View more
  6 in total

1.  Prospective comparison of three non-invasive tests for pancreatic disease.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

2.  Prospective comparison of three non-invasive tests for pancreatic disease.

Authors:  P N Foster; C J Mitchell; D R Robertson; I Hamilton; H Irving; J Kelleher; D J Lintott; P J Robinson; A T Axon; M S Losowsky
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

Review 3.  Function tests in the diagnosis of chronic pancreatitis. Critical evaluation.

Authors:  P G Lankisch
Journal:  Int J Pancreatol       Date:  1993-08

4.  The BTPABA pancreatic function test in giardiasis.

Authors:  M Okada; T Fuchigami; S Ri; N Kohrogi; T Omae
Journal:  Postgrad Med J       Date:  1983-02       Impact factor: 2.401

5.  Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.

Authors:  A S Mee; A H Girdwood; E Walker; N H Gilinsky; R E Kottler; I N Marks
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

6.  Improved specificity of the PABA test with p-aminosalicylic acid (PAS).

Authors:  F J Hoek; F A van den Bergh; J T Klein Elhorst; J L Meijer; E Timmer; G N Tytgat
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.